R Chermat

5.1k total citations · 1 hit paper
50 papers, 4.3k citations indexed

About

R Chermat is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, R Chermat has authored 50 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 12 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in R Chermat's work include Neuroscience and Neuropharmacology Research (16 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Receptor Mechanisms and Signaling (6 papers). R Chermat is often cited by papers focused on Neuroscience and Neuropharmacology Research (16 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Receptor Mechanisms and Signaling (6 papers). R Chermat collaborates with scholars based in France and Algeria. R Chermat's co-authors include Pierre Simon, Lucien Stéru, Bernard Thierry, Martine Poncelet, Alain Puech, Roger D. Porsolt, J.A. Micó, Antoine Lenègre, P. Soubri� and Marie-H�l�ne Thi�bot and has published in prestigious journals such as Cellular and Molecular Life Sciences, Life Sciences and Psychopharmacology.

In The Last Decade

R Chermat

49 papers receiving 4.1k citations

Hit Papers

The tail suspension test: A new method for screening anti... 1985 2026 1998 2012 1985 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Chermat France 20 1.9k 1.2k 986 985 616 50 4.3k
Lucien Stéru France 10 1.5k 0.8× 924 0.8× 952 1.0× 905 0.9× 542 0.9× 13 3.8k
N. Blavet France 12 1.6k 0.9× 830 0.7× 578 0.6× 1.1k 1.1× 446 0.7× 17 3.5k
Richard G. Lister United States 29 2.8k 1.5× 1.1k 0.9× 309 0.3× 974 1.0× 413 0.7× 65 5.2k
Philippe Chopin France 17 2.9k 1.6× 1.4k 1.1× 544 0.6× 1.7k 1.7× 499 0.8× 33 6.0k
Martine Hascoët France 28 1.7k 0.9× 899 0.7× 472 0.5× 824 0.8× 410 0.7× 58 3.5k
Franco Borsini Italy 41 3.5k 1.8× 2.0k 1.6× 507 0.5× 1.1k 1.1× 933 1.5× 152 6.1k
Sharon Pellow United Kingdom 26 4.2k 2.2× 1.7k 1.4× 670 0.7× 2.2k 2.2× 590 1.0× 47 7.9k
B. E. Leonard Ireland 36 2.1k 1.1× 1.1k 0.9× 1.5k 1.6× 1.6k 1.6× 826 1.3× 192 5.4k
Francisca Cléa Florenço de Sousa Brazil 40 1.0k 0.6× 963 0.8× 907 0.9× 525 0.5× 553 0.9× 152 4.4k
Paul Moser France 28 1.8k 1.0× 1.2k 1.0× 420 0.4× 522 0.5× 445 0.7× 71 3.5k

Countries citing papers authored by R Chermat

Since Specialization
Citations

This map shows the geographic impact of R Chermat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Chermat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Chermat more than expected).

Fields of papers citing papers by R Chermat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Chermat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Chermat. The network helps show where R Chermat may publish in the future.

Co-authorship network of co-authors of R Chermat

This figure shows the co-authorship network connecting the top 25 collaborators of R Chermat. A scholar is included among the top collaborators of R Chermat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Chermat. R Chermat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chermat, R. (1997). Interactions of Ginkgo biloba Extract (EGb 761), Diazepam and Ethyl β-Carboline-3-Carboxylate on Social Behavior of the Rat. Pharmacology Biochemistry and Behavior. 56(2). 333–339. 19 indexed citations
3.
Bensimon, Gilbert & R Chermat. (1991). Microtubule disruption and cognitive defects: Effect of colchicine on learning behavior in rats. Pharmacology Biochemistry and Behavior. 38(1). 141–145. 57 indexed citations
4.
Lenègre, Antoine, et al.. (1988). Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse. Pharmacology Biochemistry and Behavior. 29(3). 625–629. 36 indexed citations
5.
Stéru, Lucien, R Chermat, Bernard Thierry, et al.. (1987). The automated tail suspension test: A computerized device which differentiates psychotropic drugs. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 11(6). IN1–671. 179 indexed citations
6.
Dordain, G, et al.. (1986). Psychopharmacological profile of salsolinol. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 10(6). 691–695. 3 indexed citations
8.
Poncelet, Martine, et al.. (1986). Antidepressant-like effects of diphenylhydantoin in mice: Involvement of α-adrenoceptors. European Journal of Pharmacology. 120(1). 133–135. 7 indexed citations
9.
Stéru, Lucien, R Chermat, Bernard Thierry, & Pierre Simon. (1985). The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology. 85(3). 367–370. 2942 indexed citations breakdown →
10.
Simon, Pierre, Martine Poncelet, & R Chermat. (1985). Persistence of central effects of pirlindole, a short‐acting monoamineoxidase inhibitor, in the presence of a monoamineoxidase inhibitor. Drug Development Research. 5(4). 323–326. 2 indexed citations
11.
Simon, Pierre, R Chermat, & Alain Puech. (1983). Pharmacological evidence of the stimulation of central alpha-adrenergic receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 7(2-3). 183–186. 8 indexed citations
12.
Bourin, Michel, Puech Aj, R Chermat, et al.. (1981). [The new versus the old antidepressant drugs: a comparative study of their psychopharmacological profiles (author's transl)].. PubMed. 7(3). 235–42. 6 indexed citations
13.
14.
Chermat, R, Pierre Simon, & Boissier. (1979). Amoxapine in experimental psychopharmacology: a neuroleptic or an antidepressant?. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(5). 814–20. 28 indexed citations
15.
Soubrié, P., R Chermat, Martine Poncelet, & Perikles Simon. (1978). [Models of inhibition in animal behavior].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4(5 Suppl). 503–11. 3 indexed citations
16.
Chermat, R, et al.. (1978). [Experimental antiulcer activity of zolimidine].. PubMed. 32(5). 643–8. 3 indexed citations
17.
Puech, Alain, Pierre Simon, R Chermat, & J R Boissier. (1977). Bromocriptin and methylergometrine : Pharmacological approach of the mechanism of their central effects. Pharmacological Research Communications. 9(3). 299–306. 15 indexed citations
18.
Simon, P, R Chermat, & J R Boissier. (1975). [Comparison of the sedative effects of 2 alpha-sympathomimetic antihypertensive agents: clonidine and tiamenidine].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(6). 855–61. 1 indexed citations
19.
Simon, Peter F. W., et al.. (1974). [Psychopharmalogical study of a central alpha-sympathomimetic agent, xylazine analgesic and tranquillizer in veterinary medicine].. PubMed. 28(4). 735–51. 1 indexed citations
20.
Chermat, R, et al.. (1966). [Technic of rapid selection of antitussive substances. Application to the evaluation of a derivative of promethazine].. PubMed. 24(3). 181–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026